CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Vemurafenib effectively controlled Chemotherapy-refractory Intrahepatic Cholangiocarcinoma with BRAF V600E Mutation: a case report and literature review
DOI 10.1055/a-1826-2814
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMengyuan Yang, Liuhong Wang, Ying Yuan
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe12/2022
Jahrgang / SeitenJg. 60 · S. 1787-1791
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Background Chemotherapy is the first treatment option for local advanced or metastatic intrahepatic cholangiocarcinoma (ICC). However, after first-line chemotherapy, there is no standard second-line treatment or targeted agents for these patients. Case presentation Here we present an advanced ICC patient who has received radical resection and adjuvant chemotherapy (gemcitabine + cisplatin). But the no evide…
Zitieren
Zitierempfehlung
Mengyuan Yang, Liuhong Wang, Ying Yuan (2022) Vemurafenib effectively controlled Chemotherapy-refractory Intrahepatic Cholangiocarcinoma with BRAF V600E Mutation: a case report and literature review. Zeitschrift für Gastroenterologie, 60 (12), 1787-1791. https://doi.org/10.1055/a-1826-2814
Mit CareLit weiterarbeiten